Altamira Therapeutics Ownership 2024 | Who Owns Altamira Therapeutics Now?

OverviewChart Transcripts

Institutional Ownership

3.13%

Insider Ownership

0.89%

Retail Ownership

95.98%

Institutional Holders

11.00

Altamira Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITIGROUP INC	81.97%	-	3,074	3,074	100.00%	3,935,000	Mar 31, 2023
UBS GROUP AG	40.85%	-	1,532	-2,315	-60.18%	1,961,000	Mar 31, 2023
MORGAN STANLEY	27.33%	-	1,025	-1,470	-58.92%	1,312,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.67%	-	25	-	-	32,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.40%	-	15	15	100.00%	19,000	Mar 31, 2023
STONEBRIDGE CAPITAL ADVISORS LLC	0.13%	-	5	-	-	6,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-10,100	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-748	-100.00%	-	Mar 31, 2023

Altamira Therapeutics's largest institutional shareholder is CITIGROUP INC, holding 81.97% of the company's total share outstanding, currently valued at $3.94M. The top 10 institutional shareholders own together 151.36% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITIGROUP INC	81.97%	-	3,074	3,074	100.00%	3,935,000	Mar 31, 2023
UBS GROUP AG	40.85%	-	1,532	-2,315	-60.18%	1,961,000	Mar 31, 2023
STONEBRIDGE CAPITAL ADVISORS LLC	0.13%	-	5	-	-	6,000	Mar 31, 2023
MORGAN STANLEY	27.33%	-	1,025	-1,470	-58.92%	1,312,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.40%	-	15	15	100.00%	19,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.67%	-	25	-	-	32,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-10,100	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-748	-100.00%	-	Mar 31, 2023

The largest Altamira Therapeutics shareholder by % of total assets is CITIGROUP INC. The company owns 3.07K shares of Altamira Therapeutics (CYTO), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITIGROUP INC	81.97%	-	3,074	3,074	100.00%	3,935,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.40%	-	15	15	100.00%	19,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.67%	-	25	-	-	32,000	Mar 31, 2023
STONEBRIDGE CAPITAL ADVISORS LLC	0.13%	-	5	-	-	6,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-748	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	27.33%	-	1,025	-1,470	-58.92%	1,312,000	Mar 31, 2023
UBS GROUP AG	40.85%	-	1,532	-2,315	-60.18%	1,961,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-10,100	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Altamira Therapeutics's largest institutional buyer is CITIGROUP INC. The company purchased 3.07K stocks of CYTO, valued at $3.94M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-10,100	-100.00%	-	Mar 31, 2023
UBS GROUP AG	40.85%	-	1,532	-2,315	-60.18%	1,961,000	Mar 31, 2023
MORGAN STANLEY	27.33%	-	1,025	-1,470	-58.92%	1,312,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-748	-100.00%	-	Mar 31, 2023
STONEBRIDGE CAPITAL ADVISORS LLC	0.13%	-	5	-	-	6,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.67%	-	25	-	-	32,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.40%	-	15	15	100.00%	19,000	Mar 31, 2023
CITIGROUP INC	81.97%	-	3,074	3,074	100.00%	3,935,000	Mar 31, 2023

As of Mar 31 2023, Altamira Therapeutics's biggest institutional seller is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company sold -10.10K shares of CYTO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITIGROUP INC	81.97%	-	3,074	3,074	100.00%	3,935,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.40%	-	15	15	100.00%	19,000	Mar 31, 2023

Altamira Therapeutics's largest new institutional shareholder by number of shares is CITIGROUP INC, purchased 3.07K shares, valued at $3.94M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-10,100	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-748	-100.00%	-	Mar 31, 2023

Altamira Therapeutics's largest sold out institutional shareholder by shares sold is SUSQUEHANNA INTERNATIONAL GROUP, LLP, sold -10.10K shares, valued at -, as of undefined.

Altamira Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	11	-
30 Jun, 22	11	-26.67%
31 Mar, 22	15	-16.67%
31 Dec, 21	18	12.50%
30 Sep, 21	16	-

As of 30 Sep 22, 11 institutions are holding Altamira Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	414,334	40.62%
30 Jun, 22	294,645	-46.88%
31 Mar, 22	554,714	-2.09%
31 Dec, 21	566,577	-15.35%
30 Sep, 21	669,295	-

Altamira Therapeutics (CYTO) has 414.33K shares outstanding as of 30 Sep 22, up 40.62% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	3.13%	63.22%
30 Jun, 22	2.22%	12.68%
31 Mar, 22	4.19%	22.89%
31 Dec, 21	4.28%	16.75%
30 Sep, 21	5.05%	-

As of 30 Sep 22, Altamira Therapeutics is held by 3.13% institutional shareholders, representing a 63.22% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	6	-14.29%
30 Jun, 22	7	-22.22%
31 Mar, 22	9	-
31 Dec, 21	9	-40.00%
30 Sep, 21	15	-

6 institutional shareholders have increased their position in CYTO stock as of 30 Sep 22 compared to 7 in the previous quarter (a -14.29% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	3	-
30 Jun, 22	3	50.00%
31 Mar, 22	2	-66.67%
31 Dec, 21	6	-
30 Sep, 21	-	-

3 institutional shareholders have reduced their position in CYTO stock as of 30 Sep 22 compared to 3 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	11	-	414,334	40.62%	3.13%	63.22%	6	-14.29%	3	-
30 Jun, 22	11	-26.67%	294,645	-46.88%	2.22%	12.68%	7	-22.22%	3	50.00%
31 Mar, 22	15	-16.67%	554,714	-2.09%	4.19%	22.89%	9	-	2	-66.67%
31 Dec, 21	18	12.50%	566,577	-15.35%	4.28%	16.75%	9	-40.00%	6	-
30 Sep, 21	16	-	669,295	-	5.05%	-	15	-	-	-

Altamira Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 12, 2008	CARTER STEPHEN	director	-	D-Return	Sell	10,000	$0.62	$6.20K	-
May 09, 2008	LOKAY KEVIN G	director	-	D-Return	Sell	185,439	$0.62	$114.97K	-
May 09, 2008	LOKAY KEVIN G	director	-	D-Return	Sell	100,000	$0.57	$57.00K	-
May 09, 2008	MOLLICA JOSEPH A	director	-	D-Return	Sell	10,000	$0.62	$6.20K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 12, 2008	CARTER STEPHEN	director	-	D-Return	Sell	10,000	$0.62	$6.20K	-
May 09, 2008	LOKAY KEVIN G	director	-	D-Return	Sell	185,439	$0.62	$114.97K	-
May 09, 2008	LOKAY KEVIN G	director	-	D-Return	Sell	100,000	$0.57	$57.00K	-
May 09, 2008	MOLLICA JOSEPH A	director	-	D-Return	Sell	10,000	$0.62	$6.20K	-
Nov 15, 2007	LOKAY KEVIN G	director, officer	CEO, President & Director	A-Award	Buy	500,000	$0.57	$285.00K	500,000
Nov 15, 2007	LOKAY KEVIN G	director, officer	CEO, President & Director	A-Award	Buy	350,877	$0.57	$200.00K	350,877
Nov 15, 2007	LOKAY KEVIN G	director, officer	CEO, President & Director	A-Award	Buy	175,439	$0.57	$100.00K	175,439
Jun 15, 2007	LOKAY KEVIN G	director	-	A-Award	Buy	10,000	$2.00	$20.00K	10,000
Jun 15, 2007	LOKAY KEVIN G	director	-	A-Award	Buy	10,000	-	-	10,000
Jun 15, 2007	MOLLICA JOSEPH A	director	-	A-Award	Buy	10,000	-	-	10,000
Jun 15, 2007	MOLLICA JOSEPH A	director	-	A-Award	Buy	10,000	$2.00	$20.00K	10,000
Jun 15, 2006	LOKAY KEVIN G	director	-	A-Award	Buy	10,000	$2.95	$29.50K	10,000
Jun 15, 2006	MOLLICA JOSEPH A	director	-	A-Award	Buy	10,000	$2.95	$29.50K	10,000
Apr 06, 2006	SCHNITTKER CHRISTOPHER P	officer	Senior VP & CFO	A-Award	Buy	30,000	-	-	30,000
Apr 06, 2006	SCHNITTKER CHRISTOPHER P	officer	Senior VP & CFO	A-Award	Buy	8,100	-	-	21,139
Sep 27, 2005	MOLLICA JOSEPH A	director	-	A-Award	Buy	477	-	-	2,000
Aug 10, 2005	MOLLICA JOSEPH A	director	-	A-Award	Buy	406	-	-	1,523
Aug 05, 2005	MOLLICA JOSEPH A	director	-	A-Award	Buy	197	-	-	1,117
Aug 03, 2005	MOLLICA JOSEPH A	director	-	A-Award	Buy	98	-	-	920
Jul 22, 2005	MOLLICA JOSEPH A	director	-	A-Award	Buy	198	-	-	822

The last insider sell of Altamira Therapeutics's stock was made by CARTER STEPHEN on May 12 2008, selling 10,000 shares at $0.62 per share (valued at $6.20K).

Altamira Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Altamira Therapeutics Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
VECT	VectivBio Holding AG
AVRO	AVROBIO, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
PYXS	Pyxis Oncology, Inc.
ZURA	Zura Bio Limited
ELEV	Elevation Oncology, Inc.
ENVB	Enveric Biosciences, Inc.
PALI	Palisade Bio, Inc.

CYTO Ownership FAQ

Who Owns Altamira Therapeutics?

Altamira Therapeutics is owned by institutional shareholders (3.13%), insiders (0.89%), and public (95.98%). The largest institutional shareholder of Altamira Therapeutics is CITIGROUP INC (81.97% of total shares) and the top mutual fund owner is (0% of total shares).

Who are the major institutional shareholders of Altamira Therapeutics?

Altamira Therapeutics's major institutional shareholders are CITIGROUP INC, UBS GROUP AG, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, and ADVISOR GROUP HOLDINGS, INC.. The top five shareholders own together 151.23% of the company's share outstanding.

How many Altamira Therapeutics shareholders are there?

As of Sep 2022, there are 11 institutional shareholders of Altamira Therapeutics.

What percentage of Altamira Therapeutics is owned by CITIGROUP INC?

CITIGROUP INC owns 3.07K shares of Altamira Therapeutics, representing 81.97% of the company's total shares outstanding, valued at $3.94M (as of Mar 2023).

What percentage of Altamira Therapeutics is owned by UBS GROUP AG?

As of Mar 2023, UBS GROUP AG holds 1.53K shares of Altamira Therapeutics (CYTO), compromising 40.85% of the company, valued at $1.96M.

What percentage of Altamira Therapeutics is owned by MORGAN STANLEY?

MORGAN STANLEY is the third largest holder of Altamira Therapeutics. The company owns 1.02K of the company's shares outstanding (worth $1.31M).